|
|
Volumn 12, Issue 1 Suppl 1, 2007, Pages 11-14
|
|
Measuring disease modification in Alzheimer's disease.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
NEUROPROTECTIVE AGENT;
NOOTROPIC AGENT;
ALZHEIMER DISEASE;
ANIMAL;
ARTICLE;
BRAIN;
CLINICAL TRIAL;
DIAGNOSTIC IMAGING;
DISEASE MODEL;
DRUG EFFECT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MENTAL HEALTH;
METABOLISM;
PARASITOLOGY;
TREATMENT OUTCOME;
UNITED STATES;
ALZHEIMER DISEASE;
ANIMALS;
BIOLOGICAL MARKERS;
BRAIN;
CLINICAL TRIALS;
DIAGNOSTIC IMAGING;
DISEASE MODELS, ANIMAL;
HUMANS;
MENTAL STATUS SCHEDULE;
NEUROPROTECTIVE AGENTS;
NOOTROPIC AGENTS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
|
EID: 34848844415
PISSN: 10928529
EISSN: None
Source Type: Journal
DOI: 10.1017/s109285290002589x Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
